Sara Rattotti

2.6k total citations
44 papers, 963 citations indexed

About

Sara Rattotti is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Sara Rattotti has authored 44 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 27 papers in Genetics and 16 papers in Oncology. Recurrent topics in Sara Rattotti's work include Lymphoma Diagnosis and Treatment (33 papers), Chronic Lymphocytic Leukemia Research (27 papers) and Viral-associated cancers and disorders (13 papers). Sara Rattotti is often cited by papers focused on Lymphoma Diagnosis and Treatment (33 papers), Chronic Lymphocytic Leukemia Research (27 papers) and Viral-associated cancers and disorders (13 papers). Sara Rattotti collaborates with scholars based in Italy, Germany and Denmark. Sara Rattotti's co-authors include Luca Arcaini, Marco Paulli, Michele Merli, Emanuela Boveri, Cristiana Pascutto, Marzia Varettoni, Silvia Zibellini, Manuel Gotti, Mario Cazzola and Marco Lucioni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sara Rattotti

42 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Rattotti Italy	16	655	595	278	225	148	44	963
Masahiro Yokoyama Japan	15	575 0.9×	325 0.5×	461 1.7×	185 0.8×	116 0.8×	61	1.0k
Michele Merli Italy	17	474 0.7×	705 1.2×	329 1.2×	101 0.4×	303 2.0×	64	1.1k
Martin‐Leo Hansmann Germany	18	819 1.3×	258 0.4×	530 1.9×	352 1.6×	163 1.1×	27	1.3k
Katayoun Jondeau France	8	305 0.5×	339 0.6×	245 0.9×	113 0.5×	121 0.8×	18	885
Manuel Gotti Italy	13	819 1.3×	389 0.7×	374 1.3×	188 0.8×	47 0.3×	39	1.0k
Sang Eun Yoon South Korea	16	475 0.7×	110 0.2×	537 1.9×	259 1.2×	151 1.0×	102	949
Junning Cao China	16	381 0.6×	109 0.2×	553 2.0×	140 0.6×	136 0.9×	90	907
Liliana Calabrese Italy	11	364 0.6×	180 0.3×	184 0.7×	88 0.4×	49 0.3×	29	743
T. Economopoulos Greece	18	318 0.5×	446 0.7×	359 1.3×	210 0.9×	178 1.2×	45	1.1k
Hui-Qiang Huang China	22	740 1.1×	151 0.3×	819 2.9×	451 2.0×	190 1.3×	51	1.4k

Countries citing papers authored by Sara Rattotti

Since Specialization

Citations

This map shows the geographic impact of Sara Rattotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Rattotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Rattotti more than expected).

Fields of papers citing papers by Sara Rattotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Rattotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Rattotti. The network helps show where Sara Rattotti may publish in the future.

Co-authorship network of co-authors of Sara Rattotti

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Rattotti. A scholar is included among the top collaborators of Sara Rattotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Rattotti. Sara Rattotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zuccaro, Valentina, Marta Corbella, Erika Asperges, et al.. (2023). Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study. Microorganisms. 11(5). 1305–1305. 2 indexed citations

Gragnani, Laura, Sara Rattotti, Silvia Zibellini, et al.. (2022). B‐cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non‐Hodgkin's Lymphoma. Hematological Oncology. 40(4). 658–666. 7 indexed citations

Colaneri, Marta, Silvia Roda, Alessandra Ricciardi, et al.. (2022). Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy. Journal of Clinical Medicine. 11(24). 7452–7452. 2 indexed citations

Defrancesco, Irene, Sara Rattotti, Michele Merli, et al.. (2020). HCV infection and non-Hodgkin lymphomas: an evolving story. Clinical and Experimental Medicine. 20(3). 321–328. 11 indexed citations

Defrancesco, Irene, Silvia Zibellini, Emanuela Boveri, et al.. (2020). Targeted next‐generation sequencing reveals molecular heterogeneity in non‐chronic lymphocytic leukemia clonal B‐cell lymphocytosis. Hematological Oncology. 38(5). 689–697. 4 indexed citations

Anastasia, Antonella, Annalisa Chiarenza, Luigi Marcheselli, et al.. (2019). Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL). British Journal of Haematology. 185(4). 713–717. 18 indexed citations

Varettoni, Marzia, Silvia Zibellini, Emanuela Boveri, et al.. (2019). A risk‐stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders. British Journal of Haematology. 187(4). 441–446. 16 indexed citations

Defrancesco, Irene, Silvia Zibellini, Emanuela Boveri, et al.. (2019). Targeted Next Generation Sequencing Reveals Molecular Heterogeneity in Non-CLL Clonal B-Cell Lymphocytosis. Blood. 134(Supplement_1). 1502–1502. 1 indexed citations

Rusconi, Chiara, Maria Luisa Guerrera, Alessandra Tedeschi, et al.. (2015). Outcome of Transformed Marginal Zone Lymphomas Treated in the Rituximab Era. Blood. 126(23). 5098–5098. 3 indexed citations

10.

Morra, Enrica, Marzia Varettoni, Alessandra Tedeschi, et al.. (2013). Associated Cancers in Waldenström Macroglobulinemia: Clues for Common Genetic Predisposition. Clinical Lymphoma Myeloma & Leukemia. 13(6). 700–703. 12 indexed citations

11.

Rattotti, Sara, Luca Arcaini, Virginia Valeria Ferretti, et al.. (2013). Non-Hodgkin's Lymphomas Associated With Positive Hepatitis-C Virus Infection: A Prospective Multicentric Observational Study On Behalf Of The “Rete Ematologica Lombarda/Hematology Network Of Lombardia Region”. Blood. 122(21). 3003–3003. 1 indexed citations

12.

Varettoni, Marzia, Luca Arcaini, Silvia Zibellini, et al.. (2013). Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström’s macroglobulinemia and related lymphoid neoplasms. Blood. 121(13). 2522–2528. 218 indexed citations

13.

Varettoni, Marzia, Luca Arcaini, Silvia Zibellini, et al.. (2012). Prevalence and Clinical Significance of the MYD88 (L265P) Somatic Mutation in Patients with Waldenstrom Macroglobulinemia, IgM-Monoclonal Gammopathy of Undetermined Significance or Other Mature B-Cell Neoplasms.. Blood. 120(21). 2667–2667. 2 indexed citations

14.

Arcaini, Luca, Sara Rattotti, Manuel Gotti, & Stefano Luminari. (2012). Prognostic Assessment in Patients with Indolent B-Cell Lymphomas. The Scientific World JOURNAL. 2012. 1–5. 5 indexed citations

15.

Arcaini, Luca, Daniele Vallisa, Michele Merli, et al.. (2011). Hematological response to antiviral treatment in 94 patients with indolent B-cell lymphomas associated with hepatitis C virus infection : a study of the Fondazione Italiana Linfomi (FIL). 22. 129–129. 4 indexed citations

16.

Merli, Michele, Luca Arcaini, Emanuela Boveri, et al.. (2010). Assessment of bone marrow involvement in non‐Hodgkin’s lymphomas: comparison between histology and flow cytometry. European Journal Of Haematology. 85(5). 405–415. 24 indexed citations

17.

Novara, Francesca, Luca Arcaini, Michele Merli, et al.. (2009). High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma. Human Pathology. 40(11). 1628–1637. 12 indexed citations

18.

Arcaini, Luca, Michele Merli, Francesco Passamonti, et al.. (2009). Impact of treatment‐related liver toxicity on the outcome of HCV‐positive non‐Hodgkin's lymphomas. American Journal of Hematology. 85(1). 46–50. 48 indexed citations

19.

Arcaini, Luca, Silvia Zibellini, Francesco Passamonti, et al.. (2009). Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires. Blood Cells Molecules and Diseases. 42(3). 286–291. 23 indexed citations

20.

Boveri, Emanuela, Luca Arcaini, Michele Merli, et al.. (2008). Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients. Annals of Oncology. 20(1). 129–136. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact